Clin2
NCT02779465Possibly a fitNot yet recruiting

Vitamin D to prevent liver cancer in hepatitis B patients

Hepatitis BCarcinoma, Hepatocellular

Treatments studied

Part of Cancer, Digestive system, Infections clinical trials.

This study tests whether taking vitamin D by mouth can help prevent liver cancer in people with chronic hepatitis B who are already on antiviral medication. If you have hepatitis B and are being treated at the Third Affiliated Hospital of Sun Yat-sen University, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
1,500 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have chronic hepatitis B and are currently on antiviral treatment.
  • You have no signs of liver cancer at the start of the study.
  • You are not pregnant or breastfeeding and will use effective birth control during the study.
  • You do not have kidney stones, high calcium levels, or other serious health conditions like uncontrolled diabetes or cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04843852Recruiting· Phase 1
Test vaccine added to hepatitis B treatment

This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.

Baltimore, Maryland
NCT07169656Recruiting
Study on reducing liver cancer risk in hepatitis B patients

This study looks at how well different hepatitis B treatments help lower the risk of liver cancer. It's for people with chronic hepatitis B who are already using or starting certain antiviral or interferon therapies.

Anyang
NCT07007286Not yet recruiting
Liver cancer risk study for hepatitis B patients with family history

This study is looking at how well antiviral treatments work to prevent liver cancer in people with chronic hepatitis B who have a family history of the disease. If you are over 30 and taking antiviral medication, you may be able to join.

Heilongjiang, Heilongjiang
NCT07120750Not yet recruiting
Antiviral treatment after liver cancer treatment

This study looks at whether giving antiviral medicine after liver cancer treatment helps prevent the cancer from coming back and improves overall outcomes. It is for people with hepatitis B who have had their liver cancer removed or destroyed with a procedure.

NCT05887505Not yet recruiting
Vitamin D and health outcomes after liver surgery

This study looks at whether vitamin D levels affect recovery and health after liver cancer surgery. Participants will receive a high-dose vitamin D supplement before surgery to see if it helps improve outcomes and reduce healthcare disparities.

NCT07160946Recruiting
Liver cancer risk check for people with hepatitis B

This study looks at your risk of developing liver cancer if you have hepatitis B. It uses your medical history and test results to give you a better idea of your risk and help guide next steps.

Guangzhou, Guangdong

Hear when a new Hepatitis B trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.